Articles by Leslee J. Shaw, PhD
The HCA National Disease Management Program for Coronary Disease Detection and Treatment in Women
ByLeslee J. Shaw, PhD,Lynn Tarkington, BSN,Tracy Callister, MD,Joseph Murgo, MD,April Simon, BSN,Cynthia Waller, MSN,Sal Battaglia, BS The Changing Healthcare Market and How It Has Influenced the Treatment of Cardiovascular Disease - Part I
ByEdmund R. Becker, PhD,Douglas C. Morris, MD,Steven D. Culler, PhD,Patrick D. Mauldin, PhD,Leslee J. Shaw, PhD,J. David Talley, MD,Will The Changing Healthcare Market: Outlook for the Future of Cardiovascular Disease Treatment - Part II
ByEdmund R. Becker, PhD,Douglas C. Morris, MD,Steven D. Culler, PhD,Patrick D. Mauldin, PhD,Leslee J. Shaw, PhD,J. David Talley, MD,Will Use of an Intravenous Contrast Agent (Optison) to Enhance Echocardiography: Efficacy and Cost Implications
ByLeslee J. Shaw, PhD,Linda Gillam, MD,Steven Feinstein, MD,John Dent, MD,Gary Plotnick, MD,for the Optison Multicenter Study Group Cost Implications of Selective Preoperative Screening in the Care of Candidates for Peripheral Vascular Operations
ByLeslee J. Shaw, PhD,Rory Hachamovitch, MD,Mylan Cohen, MD,Daniel S. Berman, MD,Salvador Borges-Neto, MD,James E. Udelson, MD,Gary V. H